Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 335

HiFiBiO Therapeutics Establishes World-Class Scientific Advisory Board

Posted by fidest press agency su giovedì, 31 ottobre 2019

HiFiBiO Therapeutics, a pioneer in innovative biotherapeutics with a unique single-cell analytics platform for extensive immune profiling, today announced the formation of a Scientific Advisory Board (SAB) comprised of experts in immunology, oncology and cell therapy, as well as drug discovery and development. The SAB will work with the company as it continues to rapidly discover and advance its pipeline of novel antibody programs to treat cancer and autoimmune disorders. “We are privileged to have the opportunity to work closely with these internationally recognized thought leaders in our space,” said Liang Schweizer, PhD, President and CEO of HiFiBiO Therapeutics. “They bring tremendous biological understanding of cancer, autoimmune disorders and other unmet medical needs to our organization. We look forward to their contributions as we continue to refine our scientific strategy, advance our unique single-cell platform and develop more innovative antibody drugs.”

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: